Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Clinton Wrigley

Vascular & Interventional Radiology El Segundo, CA Medical Doctor

NPI 1205093580 CMS profile 1304916

2330 Utah Ave, Radiology Partners, El Segundo, CA 90245

Open in the dashboard

General payments

$8,181

198 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Clinton Wrigley of El Segundo, CA is reported in the CMS Open Payments database as having received $8,181 across 198 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 74th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,208 37
2024 General $949 31
2023 General $3,615 52
2022 General $799 20
2021 General $386 17
2020 General $287 15
2019 General $937 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Clinton Wrigley
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Clinton Wrigley were reported at $1,208. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Clinton Wrigley Vascular & Interventional Radiology median Middle half National median
2019 $937 $422 $125–$1,555 $163
2020 $287 $200 $68–$652 $114
2021 $386 $280 $99–$866 $132
2022 $799 $433 $137–$1,497 $149
2023 $3,615 $506 $152–$2,019 $160
2024 $949 $556 $175–$1,930 $164
2025 $1,208 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $3,366 44 payments
  2. Penumbra, Inc. $920 52 payments
  3. Boston Scientific Corporation $840 23 payments
  4. Stryker Corporation $685 16 payments
  5. Medtronic, Inc. $439 17 payments
  6. Ethicon US, LLC $384 4 payments
  7. Argon Medical Devices, Inc. $333 10 payments
  8. Surefire Medical, Inc. $289 13 payments
  9. Abbott Laboratories $198 2 payments
  10. Imactis Inc $161 1 payment
  11. Other $565 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,181 197 payments
  2. Honoraria $2,000 1 payment
Products named General payments · program years 2019–2025
  1. CT THROMBECTOMY SYSTEM KIT $3,806 49 payments
  2. FLOWTRIEVER CATHETER, S $3,806 49 payments
  3. Indigo System $524 24 payments
  4. OPTION $286 8 payments
  5. RUBY Coil $280 20 payments
  6. TRINAV INFUSION SYSTEM $248 9 payments
  7. NEUWAVE Flex Microwave Ablation System $199 2 payments
  8. SUPERA $198 2 payments
  9. GENERAL EMBOLICS $181 4 payments
  10. GENERAL - EMBOLICS $163 6 payments
  11. Other $2,172 77 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

42

Median for Diagnostic Radiology: 24

Drug cost

$190

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 42 $190

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 209 billing codes

Paid by Medicare

$254,619

Of which drugs: $814

Medicare patients

3,817

Average age 77

Services billed

11,768

1,895 women, 1,922 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Ischemic heart disease 57%
Atrial fibrillation 38%
COPD 37%
Chronic kidney disease 34%
Heart failure 32%
Diabetes 31%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 94 6,770 $698

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

198 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record